← All indications
Leukemia, Myeloid, Chronic-Phase
The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.
Drugs by status
Approved for this indication (3)
Phase 4 trials (4)
Phase 3 trials (14)
Phase 2 trials (87)
- allopurinol
- cladribine
- decitabine
- methylprednisolone
- dexrazoxane
- axitinib
- allogeneic natural killer cells
- plerixafor
- atezolizumab
- urea
- venetoclax
- blinatumomab
- bp1001
- busulfan
- temsirolimus
- cdx-301
- diphenhydramine
- prednisone
- succimer
- doxorubicin
- eltrombopag
- etanercept
- gemtuzumab ozogamicin
- oblimersen sodium
- naltrexone
- hemopoietic stem cell
- bone marrow derived mesenchymal stem cells
- aldesleukin
- hydroxyurea
- beclomethasone
- +57 more
Phase 1 trials (58)
- 7-hydroxystaurosporine
- afatinib
- mk-1775
- olaparib
- sorafenib
- becatecarin
- belinostat
- bms-214662
- bryostatin
- selinexor
- entinostat
- enzalutamide
- fluorouracil
- trametinib
- gti-2040
- idelalisib
- nivolumab
- ispinesib
- pembrolizumab
- lenvatinib
- milatuzumab
- tozasertib
- msk-2206
- palbociclib
- panobinostat
- pegcrisantaspase
- perifosine
- pexidartinib
- xk469
- ipilimumab
- +28 more
Other trials (6)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (13)
- Avillion
- Hamad Medical Corporation
- Il-Yang Pharm. Co., Ltd.
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- University of London
- University of Washington
- Institut Bergonié
- Newcastle University
- University of Mannheim
- Royal Liverpool & Broadgreen University Hospitals NHS Truts
- Catholic University of Korea
- Imperial College London
Organization Involved with Phase 2 Indications (67)
- PPD
- Incyte
- ChemGenex Pharmaceuticals
- Pfizer
- GWT-TUD GmbH
- Hikma
- Cancer and Leukemia Group B (CALGB)
- Case Western Reserve University
- Cancer Trials Ireland
- Cornell University
- ECOG-ACRIN Cancer Research Group
- Emory University
- Gachon University
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Inje University
- Johns Hopkins University
- Korea University
- Northwestern University
- Norwegian University of Science and Technology
- Oregon Health and Science University
- RWTH Aachen University
- Seoul National University
- Southwest Oncology Group
- Stanford University
- The Korean Society of Blood and Marrow Transplantation
- Thomas Jefferson University
- University of Heidelberg
- University of Michigan
- University of Milan
- University of South Florida
- +37 more
Organization Involved with Phase 1 Indications (13)
- Celgene
- AOP Orphan Pharmaceuticals AG
- University of Pittsburgh
- AIDS Malignancy Consortium
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Harvard University
- University of California, Irvine
- University of Colorado
- American Cancer Society, Inc.
- Damon Runyon Cancer Research Foundation
- CLL Global Research Foundation
- Johnson and Johnson
- Klinikum Wels-Grieskirchen
Organization Involved with Other Experimental Indications (1)